F., Knowlton, K
Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist
Conversely, the initiation of hormone replacement therapy a decade post-menopause may elevate the risk of cardiovascular disease, among other health concerns (177)
Worsening neurological symptoms : Progressive weakness, worsening balance problems, or deteriorating cognitive function despite treatment requires urgent assessment
There is also an increased sensitization of the excitatory neurotransmitter system, such as NMDA glutamate receptors, the reduction in the number of GABA receptors (downregulation), the shift of benzodiazepine receptors to an inverse agonist state, and compensatory changes in other components of the macromolecular GABA/benzodiazepine/chloride ionophore complex (for review see, i.e., [219,220,221,222,223,224,225])